A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin 5 mg tablets relative to Trajenta 5 mg tablets in healthy Thai participants under fasting condition

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: 0a17d4efade508b9cd859fdb54b9c407d992b210
First added on: Apr 23, 2026